Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 44 | 2 | 4 | 1 | €203.80 | €293.57 | 44.049% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €99.86 | €116.81 | 16.971% |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | €729.00 | €766.92 | 5.201% |
| Amgen Inc. | 21 | 0 | 3 | 0 | €260.70 | €294.28 | 12.882% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.85 | - | - |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €834.00 | €957.22 | 14.775% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €377.85 | €382.71 | 1.285% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.77 | €35.99 | 16.949% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.46 | €86.77 | 41.183% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €121.20 | €124.93 | 3.077% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €150.90 | €174.43 | 15.595% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €154.42 | €200.06 | 29.554% |